Mesna (2-mercaptoethane sulfonate) prevents ischemia/reperfusion induced renal oxidative damage in rats.
Reoxygenation of the ischemic tissue promotes the generation of various reactive oxygen metabolites (ROM) which are known to have deleterious effects on various cellular functions. This study was designed to determine the possible protective effect of mesna (2-Mercaptoethane Sulfonate) on renal ischemia/reperfusion (I/R) injury. Wistar albino rats were unilaterally nephrectomized, and 15 days later they were subjected to 45 min of renal pedicle occlusion followed by 6 h of reperfusion. Mesna (MESNA, 150 mg/kg, i.p.; an effective dose against I/R injury) or vehicle was administered twice, 15 min prior to ischemia and immediately before the reperfusion period. At the end of the reperfusion period, rats were killed by decapitation. Kidney samples were taken for histological examination or determination of the free radicals, renal malondialdehyde (MDA) and glutathione (GSH) levels, and myeloperoxidase (MPO) activity. Renal tissue collagen content, as a fibrosis marker was also determined. Creatinine and urea concentrations in blood were measured for the evaluation of renal function. The results demonstrated that renal I/R caused nephrotoxicity, as evidenced by increases in blood urea and creatinine levels, which was reversed by MESNA treatment. Increased free radical levels, as assessed by nitroblue-tetrazolium test were reduced with MESNA. Moreover, the decrease in GSH and increases in MDA levels, and MPO activity induced by I/R indicated that renal injury involves free radical formation. Treatment of rats with MESNA restored the reduced GSH levels while it decreased MDA levels as well as MPO activity. Increased collagen contents of the kidney tissues by I/R were reversed back to the control levels by MESNA treatment. Since MESNA administration reversed these oxidant responses, improved renal function and microscopic damage, it seems likely that MESNA protects kidney tissue against I/R induced oxidative damage.
Kabasakal
Levent
L
Department of Pharmacology, Marmara University, School of Pharmacy, Istanbul, Turkey.
Sehirli
A Ozer
AO
Cetinel
Sule
S
Cikler
Esra
E
Gedik
Nursal
N
Sener
Göksel
G
D000818:Animals; D003094:Collagen / Q000378:metabolism; D003404:Creatinine / Q000378:metabolism; D005609:Free Radicals; D005978:Glutathione / Q000378:metabolism; D007668:Kidney / Q000201:enzymology / Q000473:pathology*; D007677:Kidney Function Tests; D008297:Male; D008315:Malondialdehyde; D015080:Mesna / Q000627:therapeutic use*; D009580:Nitroblue Tetrazolium; D018384:Oxidative Stress / Q000187:drug effects*; D009195:Peroxidase / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000473:pathology / Q000517:prevention & control*
D005609:Free Radicals; D009580:Nitroblue Tetrazolium; D008315:Malondialdehyde; D003094:Collagen; D003404:Creatinine; D009195:Peroxidase; D005978:Glutathione; D015080:Mesna